Canada markets open in 1 hour 58 minutes

BioVaxys Technology Corp. (BVAXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0113+0.0012 (+12.16%)
At close: 03:04PM EST
Full screen
Loading interactive chart...
  • Baystreet

    Stocks in play: Biovaxys Technology Corp

    Announces that it has further extended its research collaboration with The Ohio State University for ...

  • CNW Group

    BioVaxys and The Ohio State University Extend Research Collaboration

    BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (5LB: FRA) ("BioVaxys" or "the Company"), is pleased to announce that it has further extended its research collaboration with The Ohio State University ("The Ohio State") for SARS-CoV-2, SARS-CoV-1, and pan-sarbecovirus vaccine research. This is the second twelve-month extension of the research collaboration between BioVaxys and the University since 2021.

  • CNW Group

    BIOVAXYS ANNOUNCES MANAGEMENT CHANGE

    BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") regrets to announce that Dasha Enenko has resigned as CFO of the Company to pursue other opportunities. BioVaxys CEO James Passin has been appointed as Acting CFO while the Board of Directors of the Company completes the search for a new CFO.